References
- Mukherjee D, Patil CG. Epidemiology and the global burden of stroke. World Neurosurg. 76(Suppl. 6), S85–S90 (2011).
- Banerjee A, Marín F, Lip GY. A new landscape for stroke prevention in atrial fibrillation: focus on new anticoagulants, antiarrhythmic drugs, and devices. Stroke 42(11), 3316–3322 (2011).
- Ogilvie IM, Welner SA, Cowell W, Lip GY. Ischaemic stroke and bleeding rates in ‘real-world’ atrial fibrillation patients. Thromb. Haemost. 106(1), 34–44 (2011).
- Liao J, Khalid Z, Scallan C, Morillo C, O’Donnell M. Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischemic stroke: a systematic review. Stroke 38(11), 2935–2940 (2007).
- Disertori M, Lombardi F, Barlera S et al. Clinical characteristics of patients with asymptomatic recurrences of atrial fibrillation in the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial. Am. Heart J. 162(2), 382–389 (2011).
- Glotzer TV, Hellkamp AS, Zimmerman J et al.; MOST Investigators. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the Mode Selection Trial (MOST). Circulation 107(12), 1614–1619 (2003).
- Botto GL, Padeletti L, Santini M et al. Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. J. Cardiovasc. Electrophysiol. 20(3), 241–248 (2009).
- Healey JS, Connolly SJ, Gold MR et al. Subclinical atrial fibrillation and the risk of stroke. N. Engl. J. Med. 366(2), 120–129 (2012).
- Lazarus A. Remote, wireless, ambulatory monitoring of implantable pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy systems: analysis of a worldwide database. Pacing Clin. Electrophysiol. 30(1 Suppl.), S2–S12 (2007).
- Glotzer TV, Daoud EG, Wyse DG et al. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ. Arrhythm. Electrophysiol. 2(5), 474–480 (2009).
- Daoud EG, Glotzer TV, Wyse DG et al.; TRENDS Investigators. Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of TRENDS. Heart Rhythm 8(9), 1416–1423 (2011).
- Shanmugam N, Boerdlein A, Proff J et al. Detection of atrial high-rate events by continuous home monitoring: clinical significance in the heart failure-cardiac resynchronization therapy population. Europace 14(2), 230–237 (2012).
- Ip J, Waldo AL, Lip GY et al.; IMPACT Investigators. Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter – defibrillator and CRT-D devices: rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT study. Am. Heart J. 158(3), 364–370.e1 (2009).
- Fonarow GC, Reeves MJ, Smith EE et al.; GWTG-Stroke Steering Committee and Investigators. Characteristics, performance measures, and in-hospital outcomes of the first one million stroke and transient ischemic attack admissions in get with the guidelines-stroke. Circ. Cardiovasc. Qual. Outcomes 3(3), 291–302 (2010).
- Piccini JP, Daubert JP. Atrial fibrillation and stroke: it’s not necessarily all about the rhythm. Heart Rhythm 8(9), 1424–1425 (2011).
- Adams RJ, Albers G, Alberts MJ et al.; American Heart Association; American Stroke Association. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke 39(5), 1647–1652 (2008).
- Welles CC, Whooley MA, Na B, Ganz P, Schiller NB, Turakhia MP. The CHADS2 score predicts ischemic stroke in the absence of atrial fibrillation among subjects with coronary heart disease: data from the Heart and Soul Study. Am. Heart J. 162(3), 555–561 (2011).
- Boriani G, Botto GL, Padeletti L et al.; Italian AT-500 Registry Investigators. Improving stroke risk stratification using the CHADS2 and CHA2DS2-VASC risk scores in patients with paroxysmal atrial fibrillation by continuous arrhythmia burden monitoring. Stroke 42(6), 1768–1770 (2011).
- RATE Steering Committee. RATE Investigators. Registry of Atrial Tachycardia and Atrial Fibrillation Episodes in the cardiac rhythm management device population: the RATE Registry design. Am. Heart. J. 157(6), 983–987.e1 (2009).
- Kirchhof P, Lip GY, Van Gelder IC et al. Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options. executive summary of the report from the 3rd AFNET/EHRA consensus conference. Thromb. Haemost. 106(6), 1012–1019 (2011).
Website
- Early Treatment of Atrial Fibrillation for Stroke Prevention Trial (EAST). http://clinicaltrials.gov/ct2/show/NCT01288352